Treatment of hidradenitis suppurativa with etanercept injection.

Objectives: To observe the effects of etanercept treatment on the cutaneous manifestations of hidradenitis suppurative (HS) and to evaluate physician and patient global assessment scores of cutaneous manifestations.

Design: Single-center, randomized, prospective, double-blind, placebo-controlled study.

Setting: Academic dermatology practice.